Announcements Trials

Browse Landscape

Phase

Phase NA 10 Phase 2 9 Phase 1 5 Phase 3 4 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Head and Neck Neoplasms 1 Glioblastoma 1

Interventions

Dexamethasone 8 Oxycodone 6 Epoetin Alfa 5 Propofol 4 Palonosetron 4 Meropenem 4 Zoledronic Acid 3 Vancomycin 3 Sevoflurane 3 Ondansetron 3 Naloxone 3 Everolimus 3 Ciprofloxacin 3 Cholecalciferol 3 Ceftazidime 3 Cefepime 3 Calcium Dobesilate 3 Bevacizumab 3 Aspirin 3 Aprepitant 3 peginterferon alfa-2a 2 edoxaban 2 apixaban 2 apatinib 2 Vitamin B 12 2 Vincristine 2 Tobacco Use Cessation Devices 2 Teicoplanin 2 Tablets 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms × Radiosurgery × Clear all

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡